Original Research

Benefit Management Considerations for BPH Medications: Single Agent or Combination Therapy?
A Collaborative Approach to Drug Selection, Driven by Clinical Outcomes Excellence
When More Is Almost Always Better
Efficacy and Cost-Effectiveness: Escitalopram versus Citalopram
Health Plans Must “COPE” with Chronic Diseases
New Strategies Needed to Combat Increasing Costs and Optimize Use of Infused Therapies
Stakeholder Integration Crucial to Improved Patient Outcomes: Lessons from a Health Plan’s Experience
Value-Based Insurance Design: Evolving Strategies to Improve Medication Adherence, Control Healthcare Utilization
Page 10 of 10
Results 91 - 98 of 98
Copyright © Engage Healthcare Communications, LLC. All rights reserved.